Is acute myeloid leukemia treatment possible without transplant?

Yes, for favorable-risk AML or elderly patients unfit for transplant, chemotherapy with or without targeted therapy can achieve remission.

What is the AML transplant success rate?

With matched donors and early transplant during first remission, success rates range between 50%–70% depending on age, risk factors, and MRD status.

How long does acute myeloid leukemia (AML) treatment take?

Induction chemotherapy usually takes 4–6 weeks. Consolidation or transplant requires another 4–8 weeks. Post-transplant recovery may last several months.

How is acute myeloid leukemia (AML) different from chronic myeloid leukemia (CML)?

AML is acute and aggressive, requiring immediate intensive therapy. CML is a chronic disease often managed long-term with oral targeted drugs like imatinib

What is acute myeloid leukemia (AML) remission treatment?

It includes post-chemotherapy or post-transplant follow-up, MRD monitoring, immunosuppression tapering, and infection prevention to avoid relapse.

Is acute myeloid leukemia (AML) common in India?

Yes, AML is one of the most common acute leukemias in adults, and its incidence is rising in urban populations.

Can children get AML?

Yes. AML in children and adolescents requires pediatric-specific treatment protocols and is managed by our expert pediatric oncology team.

What is acute lymphocytic leukemia (ALL)?

ALL is a fast-growing cancer of the bone marrow and blood that affects lymphoid precursor cells. It occurs in both children and adults and requires immediate, specialized treatment.

What are the early symptoms of Acute Lymphocytic Leukemia (ALL)

Common symptoms include fatigue, infections, bruising or bleeding, bone pain, and swollen lymph nodes. Prompt diagnosis is essential.

How is ALL diagnosed at BMT Next?

We use CBC, bone marrow biopsy, flow cytometry, cytogenetics (e.g., BCR-ABL1), MRD testing, and next-generation sequencing to confirm the diagnosis and subtype.

What is the success rate for pediatric Acute Lymphocytic Leukemia (ALL) at BMT Next?

In standard-risk pediatric ALL, our survival rates exceed 94%, aligning with top international benchmarks.

What is the role of bone marrow transplant in ALL?

BMT is offered to patients with high-risk features, poor response to induction therapy, relapsed disease, or specific cytogenetic abnormalities like Ph+ ALL.

Can adults with ALL also be treated at BMT Next?

Yes. We treat adult ALL using age-adapted protocols and offer reduced-intensity transplant regimens when needed.

What targeted therapies do you offer for relapsed or refractory Acute Lymphocytic Leukemia (ALL)?

We provide access to Blinatumomab (BiTE), Inotuzumab ozogamicin, and TKIs for Ph+ ALL. CAR-T therapy is coordinated with leading centers in India.

How does BMT Next support international patients from Mauritius or Africa?

We offer virtual consultations, visa and travel assistance, multilingual care coordination, and continuity of treatment between India and Mauritius.

Is CAR-T cell therapy available for Acute Lymphocytic Leukemia (ALL)at BMT Next?

Yes. We collaborate with accredited CAR-T therapy partners to treat CD19+ relapsed/refractory ALL cases.

How is MRD testing used to guide treatment?

MRD (Minimal Residual Disease) testing after induction and consolidation phases helps assess treatment effectiveness and guides the need for BMT.

What are the side effects of chemotherapy for Acute Lymphocytic Leukemia (ALL)?

Side effects include neutropenia, infections, nausea, hair loss, and fatigue. We manage toxicity through supportive care and growth factor use.

Do you provide fertility preservation for young ALL patients?

Yes. We offer fertility counseling and options like sperm banking and ovarian tissue preservation before intensive chemotherapy or transplant.

How long is treatment for acute lymphocytic leukemia?

Pediatric ALL treatment typically lasts 2–3 years. Adult protocols are shorter but may include transplant or advanced therapies.

What makes BMT Next different from other leukemia centers?

We provide MRD-guided treatment, access to immunotherapy and transplant, global referrals, and unmatched survival outcomes in India.

How can I book a second opinion at BMT Next?

You can request a virtual or in-person second opinion by sharing your reports through our patient portal or contacting our coordination team directly.

Why is BMT Next considered the best center for acute lymphocytic leukemia (ALL) treatment in Gurgaon (Gurugram)?

BMT Next in Gurgaon is equipped with advanced genomic testing, CAR-T therapy access, expert-led transplant services, and participation in international clinical trials. It offers personalized care for both pediatric and adult ALL patients, combining technology, experience, and outcomes that meet global standards.

What is multiple myeloma and how is it different from other blood cancers?

Multiple myeloma is considered a cancer of plasma cells, a type of white blood cell that helps fight infection. Unlike leukemia or lymphoma, it majorly affects the bone marrow and skeletal system.

What are the early signs of multiple myeloma?

Early signs include persistent bone pain, frequent infections, unexplained fatigue, anemia, kidney dysfunction, and high calcium levels.

How is multiple myeloma diagnosed at BMT Next?

We use a combination of blood tests (SPEP, IFE, FLC), bone marrow biopsy, PET-CT or MRI, and FISH cytogenetic studies to confirm diagnosis and risk stratify the disease.

What is the role of FISH cytogenetics in myeloma diagnosis?

FISH identifies genetic abnormalities like del(17p), t(4;14), or 1q gain, which help us predict prognosis and customize treatment.

Is bone marrow transplant mandatory for all myeloma patients?

No. Autologous stem cell transplant (ASCT) is recommended for eligible patients to prolong remission, but alternatives exist for transplant-ineligible individuals.

What is CAR-T therapy and is it available at BMT Next?

CAR-T therapy involves genetically modifying a patient’s own T-cells to fight myeloma. It is available through clinical access programs at BMT Next.

. What are the treatment options for relapsed or refractory myeloma?

Options include immunomodulators like Pomalidomide, monoclonal antibodies like Daratumumab, BiTE therapies, and CAR-T cells.

How does BMT Next monitor treatment response?

We use MRD (minimal residual disease) testing via flow cytometry or NGS to monitor the depth of remission after treatment.

Are there different types of multiple myeloma?

Yes, including smoldering myeloma (asymptomatic), active myeloma (requiring treatment), and relapsed/refractory myeloma.

What support services are offered at BMT Next for myeloma patients?

Patients receive nutritional counseling, pain management, physiotherapy, renal care, and emotional wellness support throughout treatment.

What makes BMT Next the best center for multiple myeloma treatment in India?

BMT Next offers the best multiple myeloma treatment in India through its expert-led centers in Gurgaon, Hisar, Faridabad, and Mauritius. Our strength lies in bone marrow transplant excellence, MRD-based treatment, next-level FISH cytogenetics, and access to CAR-T and BiTE therapy. Patients across North India and internationally choose BMT Next for high-quality, affordable, and personalized plasma cell cancer treatment.

How can patients from Mauritius access myeloma care at BMT Next?

Our international patient desk helps with appointment scheduling, visa support, travel coordination, and follow-up teleconsultation.

How often should follow-up occur after myeloma treatment?

Follow-up is typically every 3–6 months with blood tests, MRD monitoring, and imaging when needed.

What is lenalidomide maintenance and why is it important?

Lenalidomide is used after transplant or initial therapy to maintain remission and delay progression. It is a cornerstone of long-term management.

Are affordable treatment packages available for myeloma at BMT Next?

Yes. We offer cost-effective care across Hisar, Faridabad, and Gurgaon with insurance, CGHS, and EMI support.

What is the success rate of bone marrow transplant in India?

At leading centers like BMT Next, the success rate for bone marrow transplant ranges between 70% to 90%, depending on the disease type, patient condition, and transplant match. Conditions like thalassemia, aplastic anemia, and acute leukemia show high cure rates when treated early.

How much does a bone marrow transplant cost in India?

The cost varies between ₹8 to ₹25 lakhs, based on the type of transplant. Autologous BMTs are usually less expensive than allogeneic or haploidentical transplants. BMT Next offers transparent packages in Gurgaon, Faridabad, Hisar, and Mauritius with financial counseling support.

How long does a bone marrow transplant take?

The full procedure—including pre-evaluation, transplant, and initial recovery—typically takes 4 to 6 weeks. Post-discharge monitoring continues for 6 to 12 months depending on the patient’s immune recovery.

Who can be a donor for bone marrow transplant?

Donors may be siblings, matched unrelated individuals, or half-matched (haploidentical) family members. At BMT Next, we conduct HLA typing and also work with global donor registries if a family match isn’t available

Is bone marrow transplant painful?

The transplant itself is not painful. It’s a stem cell infusion given through a vein, very similar to a blood transfusion. Pre-transplant chemotherapy may cause side effects, which are managed by our transplant care team.

Which diseases are treated with bone marrow transplant?

We treat leukemia, lymphoma, multiple myeloma, aplastic anemia, thalassemia, sickle cell anemia, MDS, and rare immunodeficiency syndromes. BMT Next specializes in both adult and pediatric BMTs across all these conditions.

Can international patients get bone marrow transplant in India?

Yes. Through our Mauritius center, international patients from Africa, the Middle East, and Indian Ocean islands can access India’s best BMT care with visa assistance, translator support, and telemedicine follow-up.

What are the risks of bone marrow transplant?

Like any major medical procedure, BMT carries risks such as infection, graft-versus-host disease (GVHD), and delayed engraftment. However, at BMT Next, we use strict infection control, ICU monitoring, and early GVHD management to minimize complications.

Why is BMT Next considered among the best bone marrow transplant centers in India?

With over 3,000+ transplants performed, MRD-guided therapy, internationally trained specialists, and a strong presence in Gurgaon, Faridabad, Hisar, and Mauritius, BMT Next combines experience with accessibility and affordability.

How soon should I consult for a bone marrow transplant?

Early consultation is critical—especially for high-risk leukemia, aplastic anemia, or relapsed cancers. Delays can affect survival. Contact BMT Next today to schedule a transplant evaluation at your nearest center.

Best Aplastic Anemia Treatment in India

Services

let us helping you by make an appointment

Lorem ipsum dolor sit amet consectetur.

At BMT Next, we provide the best aplastic anemia treatment in India by combining expert hematology care with best bone marrow transplant infrastructure. With leading centers in Gurgaon, Faridabad, Hisar, and Mauritius, we offer both immunosuppressive therapy (ATG + cyclosporine) and curative allogeneic bone marrow transplants for patients of all ages. Our multidisciplinary team follows global guidelines, including EBMT and NIH protocols, while optimizing treatment for Indian patients in terms of safety, cost, and outcomes. Whether you’re a newly diagnosed patient or seeking a second opinion, BMT Next provides trusted, accessible care for aplastic anemia across India and beyond.

Causes of Aplastic Anemia? Common Triggers in Patients

Aplastic anemia can be triggered by a wide range of factors, many of which are particularly relevant in India due to environmental exposures and infection prevalence. Common causes include autoimmune disorders, where the immune system attacks bone marrow stem cells, as well as viral infections like hepatitis B, Epstein-Barr virus, or HIV. Prolonged use of certain medications such as antibiotics, anti-epileptics, and NSAIDs can also suppress marrow activity. Additionally, exposure to industrial toxins, such as pesticides and benzene, has been linked to marrow failure. At BMT Next, we identify and address underlying causes to personalize treatment for patients across mauritius and India including Gurgaon, Hisar, and Faridabad, where environmental and lifestyle factors vary. We offer the best aplastic anemia treament in India and Mauritius!

Symptoms of Aplastic Anemia: What Patients Should Watch For

Recognizing the early symptoms of aplastic anemia is critical for timely diagnosis and intervention. The condition often begins subtly, with signs such as chronic fatigue, pale skin, and shortness of breath, which may be mistaken for common anemia. As the disease progresses, patients may experience frequent infections due to low white blood cell counts and easy bruising or bleeding caused by thrombocytopenia. Gum bleeding, heavy menstrual cycles, or pinpoint rashes may also appear. At BMT Next centers in Gurgaon, Hisar, and Faridabad, we urge families to seek prompt evaluation for unexplained fatigue or infections, especially when accompanied by low blood counts. Early detection significantly improves treatment success.

How is Aplastic Anemia Diagnosed? Tests & Workup

Accurate diagnosis is the foundation of effective aplastic anemia treatment in India. At BMT Next, our centers in Gurgaon, Hisar, and Faridabad use internationally accepted protocols to evaluate bone marrow failure. The process begins with a complete blood count (CBC), which typically shows pancytopenia—low levels of red cells, white cells, and platelets. A reticulocyte count checks marrow activity, while a bone marrow biopsy confirms hypocellularity. Additional tests like flow cytometry, cytogenetics, and HLA typing are used to rule out conditions like leukemia, myelodysplastic syndrome (MDS), and PNH (paroxysmal nocturnal hemoglobinuria). This comprehensive approach allows us to decide between immunosuppressive therapy or bone marrow transplant for each patient. Choose the best aplastic anemia treatment center in India!

Immunosuppressive Therapy for Aplastic Anemia in India: ATG + Cyclosporine Protocol

For patients who are not candidates for transplant, immunosuppressive therapy (IST) remains the frontline treatment for moderate and severe aplastic anemia in India. At BMT Next centers in Gurgaon, Faridabad, and Hisar, we use a globally recommended combination of antithymocyte globulin (ATG) and cyclosporine, often supported with Eltrombopag to stimulate platelet production. This treatment is particularly effective in adults over 40 or those without a matched bone marrow donor. Studies show a response rate of 60–75% within 3–6 months of initiation. Our team monitors each patient closely for infections, liver function, and relapse. IST is a cost-effective, non-curative but powerful approach for controlling aplastic anemia in both adults and children.

Best Bone Marrow Transplant for Aplastic Anemia in India

A bone marrow transplant (BMT) is the only curative treatment for severe aplastic anemia (SAA) and very severe aplastic anemia (VSAA). At BMT Next, we specialize in allogeneic hematopoietic stem cell transplant, offering exceptional outcomes for patients in Gurgaon, Hisar, Faridabad, and Mauritius. The process involves replacing the patient’s defective marrow with healthy stem cells from a matched sibling, haploidentical family member, or a matched unrelated donor (MUD) sourced via global registries. Our transplant success rates exceed 90% in matched sibling cases and 70–75% in haploidentical settings. We ensure pre-transplant evaluations, infection control, and long-term follow-up. With expert transplant physicians and personalized protocols, we deliver safe, affordable, and curative BMT for aplastic anemia across India. We are considered the best bone marrow transplant center in gurgaon, hisar, faridabad and mauritius.

Who is Eligible for Bone Marrow Transplant in Aplastic Anemia?

Not all patients with aplastic anemia require a transplant—but for many, it is the most effective and life-saving option. At BMT Next, we recommend bone marrow transplant for patients diagnosed with severe or very severe aplastic anemia, especially those under 40 with a matched sibling donor. Patients who fail immunosuppressive therapy or have relapsed disease are also strong candidates for BMT. Pediatric cases, particularly those with rapid marrow failure, benefit significantly from early transplant. We use HLA typing and genetic risk profiling to guide transplant decisions. Our centers in Gurgaon, Hisar, and Faridabad follow international transplant eligibility guidelines and personalize every treatment plan based on age, comorbidities, and donor availability.

Types of Bone Marrow Transplant for Aplastic Anemia

At BMT Next, we offer a comprehensive range of bone marrow transplant options for aplastic anemia to suit patient-specific needs and donor availability. The gold standard is a matched sibling donor transplant (MSD), which offers the highest cure rates—up to 90%. For patients without a full sibling match, we perform haploidentical transplants using half-matched family donors, a technique perfected at our centers in Gurgaon, Hisar, and Faridabad. We also facilitate matched unrelated donor (MUD) transplants by partnering with international donor registries. Each transplant is supported by conditioning regimens, GVHD prophylaxis, and advanced monitoring. Our multidisciplinary team ensures that every procedure is safe, effective, and tailored to optimize long-term survival in both pediatric and adult patients.

What is the Cost of Aplastic Anemia Treatment in India?

At BMT Next, we offer transparent, affordable pricing for aplastic anemia treatment in India, whether you choose immunosuppressive therapy or bone marrow transplant (BMT). Our packages are customized based on disease severity, transplant type, donor availability, and comorbidities. In Gurgaon, treatment cost for matched donor transplant ranges from ₹12–15 lakhs. In Faridabad, transplant costs are between ₹9–12 lakhs, while Hisar offers expert care from ₹6–9 lakhs. Immunosuppressive therapy (ATG + Cyclosporine) ranges between ₹2.5–6 lakhs across treatment centers. For international patients, we offer complete BMT packages starting from USD 8,000–15,000 including pre-evaluation, transplant, hospital stay, ICU care, and follow-up. Financial counselling, EMI options, and insurance assistance are available.

Aplastic Anemia Treatment Success Rates in India | BMT Next Outcomes

At BMT Next, we pride ourselves on achieving some of the highest aplastic anemia treatment success rates in India through our expert-led transplant programs and advanced immunosuppressive therapy protocols. In matched sibling donor (MSD) transplants, our survival rate exceeds 90%, while haploidentical transplant success ranges from 70–75% with excellent engraftment. For patients receiving immunosuppressive therapy, we achieve a 60–75% response rate within 3–6 months of treatment initiation. Pediatric aplastic anemia patients show even higher recovery outcomes, especially in our Hisar and Faridabad centers. We utilize MRD monitoring, infection surveillance, and tailored conditioning regimens to ensure each patient receives safe, long-lasting, and life-altering care. Success is not just survival—it’s sustained quality of healthy life.

Post-Transplant Recovery in Aplastic Anemia: What Happens After BMT?

Recovery after a bone marrow transplant for aplastic anemia is a critical phase that requires structured follow-up and ongoing support. At BMT Next, we guide patients through every stage of post-BMT care at our centers in Gurgaon, Hisar, Faridabad, and for our international patients from Mauritius. The initial 2–3 weeks post-transplant involve close monitoring of white blood cell (WBC) recovery, platelet engraftment, and infection risk management. Patients may require transfusions, nutritional support, and IV antibiotics. Long-term follow-up includes monthly MRD testing, GVHD surveillance, and re-vaccination schedules. Most patients gradually resume normal activity within 3–6 months. Our care doesn’t end at discharge—it continues until full immune restoration and durable remission are achieved.

Aplastic Anemia Treatment Success Stories from Gurgaon, Hisar, Faridabad & Mauritius

At BMT Next, success isn’t just measured in survival—it’s seen in the lives rebuilt after treatment. Our patient stories span geographies and age groups, showcasing the impact of expert care. Rajeev, 38, from Gurgaon underwent a matched sibling transplant and returned to work within 4 months. Aisha, a 9-year-old from Hisar, beat severe aplastic anemia with a pediatric transplant and is now thriving in school. Joseph from Mauritius, treated at our Faridabad unit, received IST followed by a haploidentical BMT and now enjoys stable blood counts with no GVHD. These real journeys reflect our mission: delivering safe, accessible, and compassionate aplastic anemia treatment in India and beyond.

Meet Our Aplastic Anemia Specialists at BMT Next

Dr. meet kumar

Dr. Meet Kumar – Director & HOD, Hemato-Oncology and BMT

Specialties: Bone Marrow Transplant, Hematology Oncology, Aplastic Anemia
With over 1500 successful BMTs, Dr. Meet Kumar is a leading name in India for treating aplastic anemia, leukemia, and bone marrow failure syndromes. A DM in Clinical Hematology and a fellow from Tata Medical Centre and Kings College London (CAR-T therapy), Dr. Kumar has established state-run BMT programs and received national awards like ‘Hisar Gaurav’. His leadership ensures evidence-based, MRD-guided, and affordable transplant care across Gurgaon, Hisar, and Faridabad.

dr. neeraj teotia

Dr. Neeraj Teotia – Consultant, Pediatric Hemato-Oncology and BMT

Specialties: Pediatric Aplastic Anemia, Bone Marrow Failure Syndromes
A dedicated pediatric transplant expert, Dr. Neeraj Teotia trained in the UK and has performed 1000+ pediatric BMTs including in severe aplastic anemia and genetic marrow disorders. With international fellowships and experience from institutions like RGCIRC and Apollo Hospitals, Dr. Teotia leads our pediatric aplastic anemia program in Gurgaon and Mauritius, ensuring child-specific protocols and high survival outcomes.

dr. umesh kumar

Dr. Umesh Kumar – Attending Consultant, Hematology-Oncology & BMT

Specialties: Adult & Pediatric Aplastic Anemia, Leukemia, Stem Cell Transplant
Dr. Umesh Kumar brings over 7 years of experience and has participated in 800+ transplants, managing both autologous and allogeneic BMTs. Trained in Israel, Tamil Nadu, and Fortis Gurugram, he is known for his skill in treating aplastic anemia, MDS, and pancytopenia with precision. Dr. Kumar ensures seamless coordination of BMT processes and patient education at our Gurgaon and Faridabad centers.

dr. sumit joshi

Dr. Sumit Joshi – Senior Supervisor, Hemato-Oncology and BMT

Specialties: BMT Nursing Protocols, ICU Management, Post-Transplant Safety
With over 14 years of experience and 800+ BMTs managed, Dr. Sumit Joshi is a pioneer in transplant nursing and infection control. His expertise ensures that aplastic anemia patients at BMT Next receive safe, efficient, and protocol-driven care. He has worked extensively across India and Mauritius, helping standardize transplant recovery pathways across our network hospitals.

Need Help?

FAQs

Is bone marrow transplant the only cure for aplastic anemia?

Yes. A bone marrow transplant (BMT) is the only curative treatment for severe aplastic anemia. At BMT Next, we offer advanced transplant protocols that improve survival and reduce complications.

Which is the best center for aplastic anemia treatment in Gurgaon?

BMT Next is considered the best center for aplastic anemia treatment in India, with specialized units in Gurgaon, Hisar, Faridabad, and an international helpdesk for Mauritius. Our outcomes match global benchmarks.

What is the cost of aplastic anemia treatment in India?

Treatment costs vary by therapy:

Bone marrow transplant: ₹6–12 lakhs
Immunosuppressive therapy (ATG + Cyclosporine): ₹2.5–6 lakhs

We offer our patients transparent, bundled packages and assistance with insurance and subsidies.

Who is eligible for bone marrow transplant at BMT Next?

Eligibility depends on age (<70 years), disease severity, donor match, and overall health. We offer matched sibling, haploidentical, and unrelated donor transplants—backed by pre-BMT fitness assessment.

Why choose BMT Next for aplastic anemia care?

Our centers in Gurgaon, Hisar, Faridabad, and Mauritius desk offer:

Expert transplant physicians
High-end isolation units
24×7 infection control

Proven success in haploidentical and pediatric BMTs

End-to-end coordination
Visa and accommodation assistance
Personalized BMT packages

Post-treatment follow-up via teleconsults

Is the treatment covered by insurance or Ayushman Bharat?

Yes. Private insurance, CGHS, ESIC, and Ayushman Bharat cover most aplastic anemia treatments. Our financial counsellors at BMT Next handle all paperwork to ensure smooth approvals.